ASN
ENSC icon

Advisory Services Network’s Ensysce Biosciences ENSC Stock Holding History

Advisory Services Network’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-23
Closed -$368 – 2083
2023
Q4 		$368 Buy
+23
New +$370 ﹤0.01% 3665
2023
Q2 		– Sell
-23
Closed -$1.69K – 2081
2023
Q1 		$1.69K Buy
+23
New +$2.64K ﹤0.01% 3478

Other funds holding ENSC

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MSG
Main Street Group Glen Allen, Virginia $429M AUM 34.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PMFA
Plante Moran Financial Advisors Southfield, Michigan $1.55B AUM 17.93% 1-Year Est. Return

Advisory Services Network's ENSC Position: Q1 2024 in Review

Advisory Services Network sold out of Ensysce Biosciences (ENSC) in Q1 2024, closing a stake of 23 shares — an estimated $368 sold.

Advisory Services Network first reported a position in ENSC in Q1 2023 and held it in 2 quarters. The position peaked at $1.69K in Q1 2023. 10 funds tracked by Wall St. Rank hold ENSC as of Q1 2024.

  • Advisory Services Network reported no remaining Ensysce Biosciences position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 23 Ensysce Biosciences shares in Q1 2024, an estimated $368.
  • Advisory Services Network first reported a position in Ensysce Biosciences in Q1 2023 and held it in 2 quarters.
  • Advisory Services Network's Ensysce Biosciences position peaked at $1.69K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.